J&J beats quarterly sales and profit estimates on cancer drug sales

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. IONQ
2. IONS
3. AZN
4. SPY
5. ROIV
6. NVDA
7. ACN
8. ODFL
9. USO
10. LAD

Go back to J&J beats quarterly sales and profit estimates on cancer drug sales
Johnson & Johnson (NYSE: JNJ) Delayed: 269.83 -5.4 (1.96%)
Previous Close $275.23    52 Week High $126.07 
Open $271.28    52 Week Low $94.28 
Day High $271.99    P/E 56.10 
Day Low $266.88    EPS $4.81 
Volume 923,800